The fund will invest in early clinical and advanced pre-clinical life sciences companies, with a focus on oncology, immunology, inflammation, and rare diseases.

The strategy favors biology-driven research and clinically grounded development rather than AI-centric discovery platforms. Institutional investors include Phoenix Insurance, Clal Insurance, and Amitim Pension Funds, alongside significant capital from Arkin itself.

The post Biotech fund closes USD100m raise appeared first on IsraelDesks.

The confirmation follows an agreement reached earlier between the parties. Under the terms, EDGE will acquire a 30% equity stake for USD 10 million and commit an additional USD 12 million to a joint venture focused on developing and commercializing object-recognition and drone-detection technologies for global defense customers.

Thirdeye, headquartered in Netanya and listed on the Tel Aviv Stock Exchange, supplies advanced imaging and detection solutions to the Israeli defense establishment and international partners. The transaction strengthens defense-technology cooperation between the UAE and Israel and supports EDGE’s strategy to expand its portfolio through targeted investments in AI-enabled security platforms.

Read more in Globes

The post UAE confirms Israeli defense investment appeared first on IsraelDesks.

The move underscores growing demand for sophisticated legal finance solutions in the region, particularly for complex, high-value disputes.

In his new role, Krapivensky will concentrate on originating and assessing dispute investment opportunities and connecting high-quality matters with institutional and private capital.

He brings extensive cross-border experience spanning disputes, capital markets, and transactional work, having held senior roles at Clifford Chance and Taylor Wessing and gaining investment banking experience during a secondment at Rothschild & Co.

The post Omni Bridgeway sharpens strategic focus on Israel appeared first on IsraelDesks.

The Munich office will be led by Dr. Raphael Tautz and Matthias Schuhmacher and will focus on intellectual property, technology, and innovation-driven matters, supporting clients operating across Europe, Israel, and the United States.

The expansion strengthens the firm’s ability to advise Israeli-founded and international companies on cross-border IP strategy, patent prosecution and enforcement, and technology commercialization.

Munich’s position as a major European hub for life sciences, advanced manufacturing, and high-tech innovation makes it a strategic base for serving clients scaling into the EU market.

The post Pearl Cohen opens Munich office appeared first on IsraelDesks.

The Jerusalem Post, together with the Texas-Israel Alliance (TIA), announced Unicorn Rodeo, a two-day international conference scheduled for April 29–30, 2026 in Dallas.

The event aims to connect Israeli innovation with U.S. capital, policy and industry leaders, spotlighting sectors such as AI, health, energy, and defense, and offering networking, panels, and investor “reverse pitches.”

Texas’s business environment and strong bilateral ties with Israel present expansion opportunities for Israeli founders targeting U.S. markets.

Read more in The Jerusalem Post.

The post Startup Nation Texas conference appeared first on IsraelDesks.

The bonds, structured in five-, 10- and 30-year maturities, priced with yields 0.9%, 1%, and 1.25% above comparable U.S. Treasury rates.

Demand reached approximately USD 36 billion, reflecting strong investor interest from pension funds, insurers and hedge funds across Europe, Asia, and the United States, according to the Accountant General’s Office led by Yali Rothenberg.

Read more in ynetglobal.

The post Israel international bond sale appeared first on IsraelDesks.

The transaction marked the company’s debut as a publicly listed issuer and strengthened its long-term financing structure. The closing date was not publicly disclosed.

S. Horowitz advised ISA Group on all aspects of the offering. The legal team included Amir Assali, Ora Cohen Shabtay, and Talia Ben-Harush from the firm’s Capital Markets Practice Group.

The post ISA Group completes Israeli bond IPO appeared first on IsraelDesks.

Founded in Tel Aviv in 2020 and backed by investors including GreatPoint Ventures and the CrowdStrike Falcon Fund, Seraphic has built a browser-native platform that protects SaaS and private web applications on managed and personal devices.

This marks one of CrowdStrike’s most significant purchases in Israel to date and its sixth acquisition in the country.

In this transaction, Freshfields Bruckhaus Deringer advised CrowdStrike out of its Silicon Valley and New York offices.

Learn more in Calcalist.

The post Israeli cyber buy strengthens CrowdStrike appeared first on IsraelDesks.

Under the terms of the agreement, Mr. Tshuva acquired 23% of the shares from Yair Landau and an additional 4% from Clal Insurance.

The investment will support Herzliya Medical Center’s ambitious expansion plans, including the development of an additional hospital facility and the establishment of new medical branches in northern and southern Israel. This strategic transaction reflects the continued growth and importance of private healthcare infrastructure in Israel’s medical landscape.

Epstein Rosenblum Maoz advised Mr. Tshuva in the transaction – led by partners Amnon Epstein, Ron Abelski, Eran Mizrahi, and Michal Gazit Molcho.

The post Leading Israeli businessman buys major stake in Herzliya Medical Center appeared first on IsraelDesks.

The round, led by funds managed by Blackstone alongside existing investors including Accel, Coatue, Lightspeed, and Sequoia Capital, underpins Cyera’s expansion of its unified data security platform for cloud, AI, and enterprise environments amid surging market demand.

Meitar advised Cyera, with the team led by Shira Azran, Alon Shafrir, Romi Levin, and Tom Maor.

Weil advised Blackstone in the funding round.

Learn more in Globes.

The post Cyera raises USD400m at USD9B valuation appeared first on IsraelDesks.